Register for free
Success
Your seat has been reserved! Please check your email for a registration confirmation and more information on how to access the event.
In this virtual event, BioPharma Dive journalists will discuss the emerging biotech ecosystem with executives, venture investors and industry experts, building on our award-winning coverage of the sector.
Over three panels, we will explore the financial and operational challenges facing early-stage drug companies and their backers. Attendees will also get to hear the latest on the scientific catalysts that are fueling the formation of new startups.
Who should attend?
Executives and employees at early-stage biotech companies
Partners and associates at biotech venture capital firms
Executives and employees at pharmaceutical company venture arms, or who are involved in private company business development
Executives and employees at biotech incubators
Other professionals or researchers in the space
Register for free
Event powered by
Biotech’s New Normal virtual event will give attendees the full spectrum on the state of biotech companies today, from the private and public financing landscape, to the construction and strategy of the companies, and the new momentum building in therapeutic areas like immunology and neuroscience.
Join us for these engaging sessions with our editorial team and industry experts:
Session 1
Financing Biotech Startups
This panel discussion will feature biotech executives and venture investors discussing the current environment for funding new drug companies, both privately and as those companies advance toward public markets.
Session 2
Building Biotechs to Last
While the biotech sector has stabilized after last year’s downturn, companies still face a difficult environment. How is that affecting their strategy and plans for growth? Join this panel discussion to hear from executives navigating these challenges.
Session 3
New Areas of Research Momentum
Scientific advances are opening up opportunities for new types of medicines, such as for those that treat diseases of the brain and immune system. In this panel discussion, you’ll hear from venture investors tasked with making bets on promising research and from drug company executives tasked with turning that potential into reality.
Questions?
Registration
Sponsorship
Other questions
If you’re interested in speaking, or have any other questions, contact us at
BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma. The newsletter and website cover topics ranging from clinical readouts to FDA approvals, gene therapy to drug pricing and M&A to research partnerships.
BioPharma Dive is a leading industry publication operated by Industry Dive, an Informa business. Industry Dive’s business journalists spark ideas and shape agendas for 15 million decision makers in 20+ competitive industries.